PD Dr. Markus Hecht

Medizinische Fakultät Department of Radiation Oncology

Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors (2021) Schweizer C, Haderlein M, Schubert P, Zhou J, Semrau S, Rutzner S, Gostian AO, et al. Conference contribution App for the Early Detection of Side Effects of Immunotherapy (2021) Goldbrunner L, Hecht M, Fietkau R, Distel L Conference contribution Low-Dose Radiotherapy is highly effective in the Treatment of painful Finger Polyarthrosis (2021) Weissmann T, Gaipl U, Putz F, Hecht M, Donaubauer AJ, Zhou J, Fietkau R, et al. Conference contribution Progress Patterns under Radioimmunotherapy - clinical Evaluation of the prospective STICI Study (2021) Schubert P, Schweizer C, Roesch J, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, et al. Conference contribution Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells (2021) Faulhaber EM, Jost T, Symank JA, Scheper J, Burkel F, Fietkau R, Hecht M, Distel L Journal article PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation (2021) Jonuscheit S, Jost T, Gajdošová F, Wrobel M, Hecht M, Fietkau R, Distel L Journal article Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. (2021) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution Radiotherapy and the immune system: More than just immune suppression (2021) Rückert M, Flohr AS, Hecht M, Gaipl U Journal article, Review article Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy (2021) Zhou JG, Liang B, Liu JG, Jin SH, He SS, Frey B, Gu N, et al. Journal article Implementation of double immune checkpoint blockade increases response rate to induction chemotherapy in head and neck cancer (2021) Semrau S, Gostian AO, Traxdorf M, Eckstein M, Rutzner S, von der Grün J, Illmer T, et al. Journal article